🇺🇸 FDA
Patent

US 12116416

Targeting intracellular target-binding determinants with intracellular antibodies

granted A61KA61K2039/505A61P

Quick answer

US patent 12116416 (Targeting intracellular target-binding determinants with intracellular antibodies) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61P, A61P35/00